Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
News > Business News

Audio By Carbonatix
4:05 PM on Wednesday, March 26
The Associated Press
HAYWARD, Calif.--(BUSINESS WIRE)--Mar 26, 2025--
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced plans to present at the upcoming 24 th Annual Needham Virtual Health Care Conference.
Pulse Biosciences’ Management is scheduled to present on Thursday, April 10, 2025, at 9:30 am ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the company’s investor website at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as the potential to improve the quality of life for patients. The Company’s proprietary CellFX ® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA, nanosecond PFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250326173688/en/
CONTACT: Investors:
Pulse Biosciences, Inc.
Jon Skinner, CFO
[email protected] Group
Philip Trip Taylor
415.937.5406
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES HEALTH PHARMACEUTICAL HEALTH TECHNOLOGY
SOURCE: Pulse Biosciences, Inc.
Copyright Business Wire 2025.
PUB: 03/26/2025 04:05 PM/DISC: 03/26/2025 04:07 PM
http://www.businesswire.com/news/home/20250326173688/en